CD24 Gene Expression as a Risk Factor for Non-Alcoholic Fatty Liver Disease
In light of increasing NAFLD prevalence, early detection and diagnosis are needed for decision-making in clinical practice and could be helpful in the management of patients with NAFLD. The goal of this study was to evaluate the diagnostic accuracy of CD24 gene expression as a non-invasive tool to d...
Main Authors: | Mona A. Amin, Halla M. Ragab, Nabila Abd El Maksoud, Wafaa Abd Elaziz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/13/5/984 |
Similar Items
-
Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease
by: Halla M. Ragab, et al.
Published: (2023-02-01) -
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS
by: Ioannis Grigoropoulos, et al.
Published: (2024-04-01) -
Inhaled CD24-Enriched Exosomes (EXO-CD24) as a Novel Immune Modulator in Respiratory Disease
by: Shiran Shapira, et al.
Published: (2023-12-01) -
Targeting CD24 in Cancer Immunotherapy
by: Wenwen Chen, et al.
Published: (2023-11-01) -
The role of CD24 as a potential biomarker for malignant pleural mesothelioma
by: Mohamed Shaaban Mousa, et al.
Published: (2023-01-01)